Endo's Fortesta To Join Crowded Testosterone Treatment Market In Q1
This article was originally published in The Pink Sheet Daily
Executive Summary
FDA approved the testosterone gel despite concerns about secondary exposure, but Fortesta will be competing against entrenched rivals and a new treatment from Eli Lilly.